Overture: A Multi-Scale Data Platform for Cancer Genomics Research
Overture:癌症基因组学研究的多尺度数据平台
基本信息
- 批准号:10669216
- 负责人:
- 金额:$ 52.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-09 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdoptionAuthorization documentationBiological MarkersCanadaCancer ModelCategoriesChildClinicalCollaborationsCollectionCommunitiesComputer softwareConsentDataData DiscoveryData Management ResourcesData ScientistData SetDemocracyDependenceDevelopmentDocumentationEducational workshopEuropeanEventFAIR principlesFeedbackFocus GroupsGenerationsGenomic Data CommonsGenomicsGoalsGrantHealthHumanIndividualInformaticsInternationalInternetLaboratoriesLife Cycle StagesMalignant NeoplasmsMedical ImagingMetadataNCI Center for Cancer ResearchOncologyOntologyPathway interactionsPatientsProtocols documentationResearchResearch PersonnelResourcesSample SizeScientific Advances and AccomplishmentsSoftware EngineeringSoftware FrameworkStandardizationSystemTestingTimeTrainingValidationVisualizationVisualization softwareauthoritybig data managementcancer genomecancer genomicscloud basedcohortcommunity engagementcost effectivedata accessdata exchangedata integrationdata managementdata portaldata resourcedata sharingdesignempowermentgenome-widegenomic datahealth dataimprovedinformatics toolinnovationinterestlarge datasetslarge scale datamultiscale datanovelopen sourceoutreachrare cancersymposiumtooltransmission processuser-friendlyweb portalwebinar
项目摘要
Project Summary/Abstract
Overture is a collection of modular, open-source software components designed to make the management of
big-data genomic projects both easy and more cost effective. The Overture system promotes FAIR data
sharing of cancer genomic datasets by overcoming the major obstacles in storing, managing, exploring, and
distributing massive genome-scale datasets.
In this proposed project, we will implement a turnkey Overture Data Management System (DMS) to provide a
complete solution to manage cancer genomic data throughout the data life cycle, and to continue lowering the
technical barriers faced by researchers in the cancer informatics community. To extend the capabilities and
potential of the Overture DMS, we will establish a new software framework for integration with third-party
visualization applications, and for data exchange with analysis platforms. This framework will empower the
community to continue developing extremely valuable visualization applications for specific research interests
and datatypes, and to contribute them as “apps” to be integrated with the Overture DMS.
Over the next five years, we will: (1) combine the core set of Overture components into a scalable DMS
installation bundle to promote both local and cloud deployment for a range of small to consortia-scale datasets;
(2) extend the DMS with third-party visualization and analysis tools through a novel software data integration
framework; (3) enhance data access controls by implementing Global Alliance for Genomics and Health
(GA4GH) Passport and Data Use Ontology standards; (3) enable federated searching within cancer datasets
across different Overture platforms; and (4) improve outreach and community resources to meet the needs of
bioinformaticians, data producers and managers, data scientists, and clinical researchers. The Overture DMS
will be a valuable resource for removing complications of large-scale data management from researchers,
allowing the advancement of scientific research by increasing data sharing and discovery.
项目摘要/摘要
Overture是一个模块化开源软件组件的集合,旨在使管理
大数据基因组项目既容易又更具成本效益。序系统促进公平数据
通过克服存储,管理,探索和的主要障碍来共享癌症基因组数据集
分发大量的基因组规模数据集。
在这个拟议的项目中,我们将实施一个交钥匙序数据管理系统(DMS),以提供
在整个数据生命周期中管理癌症基因组数据的完整解决方案,并继续降低
癌症信息社区的研究人员面临的技术障碍。扩展功能和
Overture DMS的潜力,我们将建立一个与第三方集成的新软件框架
可视化应用程序,以及用于分析平台的数据交换。这个框架将增强
社区继续为特定研究兴趣开发极有价值的可视化应用程序
和数据类型,并将它们作为“应用程序”贡献,以与Overture DMS集成。
在接下来的五年中,我们将:(1)将核心组件集合到可扩展的DMS中
安装捆绑包,以促进一系列小型和财团规模数据集的本地和云部署;
(2)通过新颖的软件数据集成,使用第三方可视化和分析工具扩展DMS
框架; (3)通过实施全球基因组和健康联盟来增强数据访问控制
(GA4GH)护照和数据使用本体学标准; (3)在癌症数据集中启用联合搜索
跨不同的序平台; (4)改善外展和社区资源以满足
生物信息学家,数据生产者和经理,数据科学家和临床研究人员。序曲DMS
将是从研究人员那里消除大规模数据管理并发症的宝贵资源
通过增加数据共享和发现,允许科学研究的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melanie Courtot其他文献
Melanie Courtot的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A Uniquely Scalable Approach to Sequence Tens of Millions of Single Cells Without Compromising Performance
一种独特的可扩展方法,可在不影响性能的情况下对数千万个单细胞进行测序
- 批准号:
10700398 - 财政年份:2023
- 资助金额:
$ 52.61万 - 项目类别:
CO-CREATE-Ex: Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
CO-CREATE-Ex:社区参与优化 COVID-19 快速评估和测试体验
- 批准号:
10617124 - 财政年份:2022
- 资助金额:
$ 52.61万 - 项目类别:
CO-CREATE-Ex: Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
CO-CREATE-Ex:社区参与优化 COVID-19 快速评估和测试体验
- 批准号:
10845417 - 财政年份:2022
- 资助金额:
$ 52.61万 - 项目类别:
Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors
儿科肉瘤和其他实体瘤儿科临床前体内检测中心
- 批准号:
10657368 - 财政年份:2021
- 资助金额:
$ 52.61万 - 项目类别:
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)
分阶段实施成瘾治疗目标药物 (SITT-MAT)
- 批准号:
10689722 - 财政年份:2021
- 资助金额:
$ 52.61万 - 项目类别: